Trust Point’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$309K Buy
2,543
+459
+22% +$54.1K 0.02% 362
2026
Q2
$211K Buy
+2,084
New +$216K 0.02% 441
2026
Q1
– Sell
-2,187
Closed -$232K – 527
2025
Q4
$232K Sell
2,187
-244
-10% -$28.3K 0.02% 434
2025
Q3
$309K Buy
2,431
+316
+15% +$37.6K 0.02% 360
2025
Q2
$259K Sell
2,115
-39
-2% -$4.45K 0.02% 329
2025
Q1
$218K Sell
2,154
-2,171
-50% -$212K 0.02% 422
2024
Q4
$399K Buy
4,325
+1,109
+34% +$109K 0.03% 345
2024
Q3
$311K Buy
3,216
+25
+0.8% +$2.25K 0.02% 389
2024
Q2
$274K Sell
3,191
-545
-15% -$45.7K 0.02% 395
2024
Q1
$309K Buy
3,736
+77
+2% +$5.64K 0.02% 403
2023
Q4
$244K Buy
+3,659
New +$237K 0.02% 441

Other funds holding EHC

Trust Point's EHC Position: Q3 2026 in Review

Trust Point increased its Encompass Health (EHC) stake by 22% in Q3 2026, buying an estimated $54.1K and bringing the position to 2,543 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #362.

Trust Point first reported a position in EHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $399K in Q4 2024. 508 funds tracked by Wall St. Rank hold EHC as of Q3 2026.

  • Trust Point held 2,543 shares of Encompass Health worth $309K as of Q3 2026.
  • Trust Point bought 459 Encompass Health shares in Q3 2026, an estimated $54.1K.
  • Encompass Health made up 0.02% of Trust Point's portfolio in Q3 2026, its #362 holding.
  • Trust Point first reported a position in Encompass Health in Q4 2023 and has held it in 11 quarters since.
  • Trust Point's Encompass Health position peaked at $399K in Q4 2024.
  • 508 funds tracked by Wall St. Rank held Encompass Health as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.